Recent News

• 02.03.2025 - Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
• 01.22.2025 - Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
• 01.21.2025 - Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
• 01.16.2025 - Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
• 01.15.2025 - Phio Pharmaceuticals Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Recent Filings

• 02.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.29.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 01.28.2025 - D Notice of Exempt Offering of Securities
• 01.28.2025 - EFFECT Notice of Effectiveness
• 01.21.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 01.17.2025 - 8-K Current report
• 01.17.2025 - 424B5 Prospectus [Rule 424(b)(5)]